Health Services Research
Latest posts by Health Services Research (see all)
- Duration to Admission and Hospital Transfers Affect Facility Rankings from the Postacute 30-Day… - Jun. 28, 2016
- Community Characteristics and Qualified Health Plan Selection during the First Open Enrollment… - Jun. 28, 2016
- A Practical Guide to Using the Positive Deviance Method in Health Services Research - Jun. 28, 2016
- Impact of a Pay-for-Performance Program on Care for Black Patients with Hypertension: Important… - Jun. 22, 2016
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.